| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $56.10 | $561k | | 06/15/2023 |
| 05/25/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 9k | $0.00 | $0 | | 05/25/2023 |
| 05/25/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 15k | $11.72 | $175.8k | | 05/25/2023 |
| 06/16/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 9.9k | $31.36 | $311.9k | | 06/16/2022 |
| 05/25/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 15k | $7.40 | $111k | | 05/25/2022 |
| 10/01/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 78.1k | $2.25 | $175.8k | | 10/01/2021 |
| 07/01/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 51.7k | $3.39 | $175.4k | | 07/01/2021 |
| 06/10/2021 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $76.09 | $760.9k | | 06/10/2021 |
| 05/21/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 12.5k | $35.49 | $443.6k | | 05/21/2021 |
| 04/01/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 70.9k | $3.05 | $216.2k | | 04/01/2021 |
| 01/26/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 850k | $3.32 | $2.8M | | 01/26/2021 |
| 01/04/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 64.8k | $2.64 | $171.1k | | 01/04/2021 |
| 10/01/2020 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 76.7k | $2.24 | $171.7k | | 10/01/2020 |
| 07/01/2020 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 64.7k | $2.56 | $165.6k | | 07/01/2020 |
| 06/18/2020 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 84.3k | $2.51 | $211.6k | | 06/18/2020 |
| 06/09/2020 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 100k | $2.50 | $250k | | 06/09/2020 |
| 06/09/2020 | Aevi Genomic Medicine, Inc. | CERC | Purchase | Common Stock | 100k | $2.50 | $250k | | 06/09/2020 |
| 06/09/2020 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $36.47 | $364.7k | | 06/09/2020 |
| 05/21/2020 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option | 10k | $36.85 | $368.5k | | 05/21/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Common Stock | 2.3M | $0.00 | $0 | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 17.3k | $6.45 | $111.8k | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 292.1k | $7.01 | $2M | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 250k | $4.83 | $1.2M | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 250k | $4.91 | $1.2M | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 450k | $1.51 | $679.5k | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 661k | $1.55 | $1M | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 50k | $1.32 | $66k | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 1.5M | $4.22 | $6.3M | | 02/03/2020 |
| 02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Warrant (Right to Buy) | 21.2k | $2.84 | $60.2k | | 02/03/2020 |
| 02/03/2020 | Avalo Therapeutics, Inc. | CERC | Grant | Common Stock | 75.7k | $0.00 | $0 | | 02/03/2020 |
| 02/03/2020 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 1.2M | $3.98 | $4.8M | | 02/03/2020 |
| 12/05/2019 | Aevi Genomic Medicine, Inc. | CERC | Purchase | Common Stock | 2M | $0.13 | $274.6k | | 12/05/2019 |
| 10/29/2019 | Phathom Pharmaceuticals, Inc. | PHAT | Purchase | Common Stock | 9.8k | $19.00 | $186.2k | | 10/29/2019 |
| 06/13/2019 | Vanda Pharmaceuticals Inc. | VNDA | Grant | Stock Option (Right to Buy) | 10k | $15.04 | $150.4k | | 06/13/2019 |
| 06/13/2019 | Vanda Pharmaceuticals Inc. | VNDA | Grant | Common Stock | 5k | $0.00 | $0 | | 06/13/2019 |
|